Search Results Search Sort by RelevanceMost Recent AMA Code Says Oct 2012 AMA Code of Medical Ethics’ Opinion on Confidential Services for Children and Adolescents AMA Council on Ethical and Judicial Affairs The AMA Code of Medical Ethics' opinions on confidential services for children and adolescents. Virtual Mentor. 2012;14(10):778-779. doi: 10.1001/virtualmentor.2012.14.10.coet1-1210. AMA Code Says Oct 2011 AMA Code of Medical Ethics’ Opinions on Physicians’ Health and Conduct AMA Council on Ethical and Judicial Affairs The AMA Code of Medical Ethics’ opinions on physicians’ health and conduct. Virtual Mentor. 2011;13(10):700-702. doi: 10.1001/virtualmentor.2011.13.10.coet1-1110. Podcast Jul 2024 Ethics Talk: Street Health Care as Harm Reduction Dr Jim Withers and Dave Lettrich join Ethics talk to discuss how street outreach programs help mitigate harms of drug use among people experiencing homelessness. Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3
AMA Code Says Oct 2012 AMA Code of Medical Ethics’ Opinion on Confidential Services for Children and Adolescents AMA Council on Ethical and Judicial Affairs The AMA Code of Medical Ethics' opinions on confidential services for children and adolescents. Virtual Mentor. 2012;14(10):778-779. doi: 10.1001/virtualmentor.2012.14.10.coet1-1210.
AMA Code Says Oct 2011 AMA Code of Medical Ethics’ Opinions on Physicians’ Health and Conduct AMA Council on Ethical and Judicial Affairs The AMA Code of Medical Ethics’ opinions on physicians’ health and conduct. Virtual Mentor. 2011;13(10):700-702. doi: 10.1001/virtualmentor.2011.13.10.coet1-1110.
Podcast Jul 2024 Ethics Talk: Street Health Care as Harm Reduction Dr Jim Withers and Dave Lettrich join Ethics talk to discuss how street outreach programs help mitigate harms of drug use among people experiencing homelessness.
Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.